PHARMACEUTICAL COMPOUNDING: AN ALTERNATIVE TREATMENT OPTION IN PSORIASIS

• In: What’s new in industry and science? Part 1 on Monday, 23 September 2019, 15:30-15:40
• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Presentation
• By: SONG, Guiyun (PCCA, Research and Development, United States)
• Co-author(s): Guiyun Song: PCCA, Houston, United States
  Yashoda Pramar: PCCA, Houston, United States
  Daniel Banov: PCCA, Houston, United States
  August S. Bassani: PCCA, Houston, United States
  
• Abstract:

  Background

  Psoriasis is a chronic, immune-mediated inflammatory skin disease that causes significant burden to both the patients and the healthcare system.  Commercial medicines including corticosteroids and vitamin D analogues are often used in the topical management of psoriasis due to anti-inflammatory and/or antiproliferative properties. 

  Met..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login